Introducing our latest test kit for detecting Igg and Igm antibodies. This test kit is designed to provide efficient and accurate results for the detection of these antibodies in the blood. With the capability to test for both Igg and Igm antibodies, our product offers a comprehensive solution for healthcare professionals and individuals alike. The test kit is easy to use and requires only a small sample of blood for analysis. The results are quick, typically available within minutes, allowing for prompt decision-making and treatment planning. Our test kit is particularly valuable for identifying past infections (Igg antibodies) and current or recent infections (Igm antibodies). This versatile test kit is suitable for use in various settings, including hospitals, clinics, and laboratories, as well as for at-home testing. Its accuracy and reliability make it a valuable tool for monitoring and managing infectious diseases, including COVID-19, hepatitis, and other viral or bacterial infections. We are committed to providing high-quality diagnostic tools to support healthcare professionals and individuals in their efforts to combat infectious diseases. Our test kit for Igg and Igm antibodies is just one example of our dedication to innovation and excellence in healthcare. We are confident that this product will prove to be an invaluable asset in the fight against infectious diseases.

Beijing, China - In a groundbreaking development, researchers at Beijing Beier Bioengineering Co., Ltd. have announced a major breakthrough in the fight against Treponema Pallidum, the bacterium that

Beijing Beier Bioengineering Co., Ltd., a high-tech enterprise in China specializing in the development and production of in vitro diagnostic reagents, has recently introduced a new Rtk Antigen Self T